Search

everythinglearnresearchcommunity

for

Search:↓

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

AGA might indicate higher risk for severe COVID-19.

Hydroxychloroquine might help prevent COVID-19, but more research is needed.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Hair loss doesn't affect COVID-19 severity.

Male hormones may make COVID-19 worse, while substances that block these hormones could lessen symptoms.

Most skin reactions to COVID-19 vaccines in India were mild and not a reason to avoid vaccination.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Lichen planopilaris in men often involves scalp redness and itching, with some also having hair loss, mucosal lichen planus, or thyroid disease, and treatment improved symptoms in nearly half of the cases.

Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.

Social media data can help track COVID-19 symptoms and predict the pandemic's status.

Long-term effects of COVID-19 can vary over time and are more likely in certain age and gender groups, while race, income, and education levels have little to no impact. Ongoing medical care is needed due to potential complications.

Psoriasis treatments don't raise severe COVID-19 risk, except for acitretin.

Many hospitalized children with COVID-19 had skin, mouth, or nail changes, with skin rashes being common.

Some people still have COVID-19 symptoms after 90 days, especially older patients and those with severe initial symptoms, but most return to normal.

Certain skin symptoms in COVID-19 patients may indicate a more severe illness.

Lifestyle changes during the early COVID-19 outbreak led to more cases of acne and other skin conditions, but fewer cases of rosacea and skin infections.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

Skin problems like rashes and hair loss can help diagnose and predict COVID-19.

Many doctors lack knowledge about COVID-19 skin symptoms and need better education and guidelines.

Convalescent Plasma Therapy may help treat COVID-19 Long-Hauler symptoms.

Frankincense may help treat COVID-19, but more research is needed.

The Gabrin sign may help identify COVID-19 patients at high risk who also have hair loss due to male hormones.

Tailored neurorehabilitation programs improve life quality for post-COVID-19 patients.

Older people with severe COVID-19, especially those with certain health conditions, are more likely to experience post-COVID syndrome.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

Many healthcare workers who had Covid-19 suffer from long-term symptoms like hair loss and fatigue, especially women.

Zinc acetate hydrate may help reduce fatigue and hair loss in post-COVID-19 patients.

The article concludes that schoolchildren and adolescents experienced various skin issues during the COVID-19 pandemic, including acne from masks and other skin reactions from the virus and vaccines.